DE3825118A1 - Expression of the virally encoded protease P2A of HRV2 - Google Patents

Expression of the virally encoded protease P2A of HRV2

Info

Publication number
DE3825118A1
DE3825118A1 DE19883825118 DE3825118A DE3825118A1 DE 3825118 A1 DE3825118 A1 DE 3825118A1 DE 19883825118 DE19883825118 DE 19883825118 DE 3825118 A DE3825118 A DE 3825118A DE 3825118 A1 DE3825118 A1 DE 3825118A1
Authority
DE
Germany
Prior art keywords
expression
hrv2
virally encoded
encoded protease
dna molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19883825118
Other languages
German (de)
Inventor
Wolfgang Dr Sommergruber
Friederike Dipl Ing Fessl
Ernst Prof Dr Kuechler
Dieter Dipl Ing Dr Blaas
Timothy Dr Skern
Manfred Zorn
Markus Duechler
Heinrich Kowalski
Peter Dr Volkmann
Ingrid Dr Maurer-Fogy
Peter Dr Pallai
Vincent Dr Merluzzi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Priority to DE19883825118 priority Critical patent/DE3825118A1/en
Priority to ES88121480T priority patent/ES2059482T3/en
Priority to DE88121480T priority patent/DE3885431D1/en
Priority to AT88121480T priority patent/ATE96839T1/en
Priority to EP88121480A priority patent/EP0321973B1/en
Priority to JP63325729A priority patent/JPH0231678A/en
Priority to US07/288,894 priority patent/US5149783A/en
Publication of DE3825118A1 publication Critical patent/DE3825118A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32711—Rhinovirus
    • C12N2770/32722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to DNA molecules which code for fusion proteins composed of enzymatically active portions and of polypeptide portions which can be cleaved off the latter, to expression systems which contain these DNA molecules, and to the use of these as test systems for inhibitors of viral proteases.
DE19883825118 1987-12-23 1988-07-23 Expression of the virally encoded protease P2A of HRV2 Withdrawn DE3825118A1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE19883825118 DE3825118A1 (en) 1988-07-23 1988-07-23 Expression of the virally encoded protease P2A of HRV2
ES88121480T ES2059482T3 (en) 1987-12-23 1988-12-22 EXPRESSION OF HRV2 PROTEASE P2A CODED BY VIRUSES.
DE88121480T DE3885431D1 (en) 1987-12-23 1988-12-22 Expression of the virally encoded protease P2A of HRV2.
AT88121480T ATE96839T1 (en) 1987-12-23 1988-12-22 EXPRESSION OF THE VIRAL ENCODED PROTEASE P2A OF HRV2.
EP88121480A EP0321973B1 (en) 1987-12-23 1988-12-22 Expression of the virally encoded protease P2A of HRV2
JP63325729A JPH0231678A (en) 1987-12-23 1988-12-23 Manifestation of protease p2a encoded by virus hrv 2
US07/288,894 US5149783A (en) 1987-12-23 1988-12-23 Expression of the virally coded protease p2a of hrv2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19883825118 DE3825118A1 (en) 1988-07-23 1988-07-23 Expression of the virally encoded protease P2A of HRV2

Publications (1)

Publication Number Publication Date
DE3825118A1 true DE3825118A1 (en) 1990-01-25

Family

ID=6359429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19883825118 Withdrawn DE3825118A1 (en) 1987-12-23 1988-07-23 Expression of the virally encoded protease P2A of HRV2

Country Status (1)

Country Link
DE (1) DE3825118A1 (en)

Similar Documents

Publication Publication Date Title
NO1996012I1 (en) Betaferon
DE3852074D1 (en) METHOD FOR PURIFYING RECOMBINANT POLYPEPTIDES.
ATE380875T1 (en) CHIMERIC PROTEINS TO AVOID COMPLEMENT ACTIVATION
YU8997A (en) Purified protein having serinic proteaze inhibiting activity and pharmaceutical preparation containing them
NZ504114A (en) Vitamin k-dependent polypeptides such as protein C where substitution at amino acid sites 11, 12, 29, 33 or 34 affects membrane binding affinity of the protein and ultimately blood clotting ability
IL139478A0 (en) Hybrid protein
ES2059482T3 (en) EXPRESSION OF HRV2 PROTEASE P2A CODED BY VIRUSES.
KR870002848A (en) Anticoagulant, preparation method thereof and anticoagulant comprising foreign substance as active ingredient
DK244289A (en) FIBRONECTIN BINDING PROTEIN, ITS USE AND MANUFACTURING AND USE FOR USE IN THE MANUFACTURING
ZA8860B (en) Pancreatic secretory trypsin inhibitor and variants thereof produced by a recombinant host,process,expression vector and recombinant host therefor and pharmaceutical use thereof
BR9911891A (en) Proteases fused to subtilisin inhibitor variants of streptomyces
DE3786317D1 (en) PROTEIN ANALOGS OF THE TISSUE PLASMINOGEN ACTIVATOR.
DE60140493D1 (en) Process for the purification of strongly anionic proteins
DE3825118A1 (en) Expression of the virally encoded protease P2A of HRV2
ES8700051A1 (en) Dentifrice compositions containing dextranase
DE69331371T2 (en) Dictyostelium dipeptidylaminopeptidase
NZ241280A (en) Recombinant iga protease with a modified non-functional c-terminal protein sequence
Nakajima et al. Further stabilization of earthworm serine protease by chemical modification and immobilization
ATE193324T1 (en) RECOMBINANT PRODUCTION OF LACTOPEROXIDASE
SE8802176D0 (en) FUSION PROTEIN AND ITS USE
ATE134218T1 (en) METHOD FOR PURIFYING RECOMBINANT T-PA FROM THEIR CORRESPONDING HOST CELL PROTEINS
ZA200007619B (en) New peptide fragments for protein purification.
FI942623A0 (en) Recombinant viruses containing an artificial proteolytic cleavage site
DK227781A (en) PROTEOLYTIC MEDICINE AND PROCEDURE FOR PROTEIN HYDROOLYSIS UNDER USE THEREOF
DK46190A (en) ACYLPEPTID HYDROLYSE AND PROCEDURES FOR PREPARING AND USING THEREOF

Legal Events

Date Code Title Description
8141 Disposal/no request for examination